Go Pro

Oppenheimer (OPY) Financials

Oppenheimer logo
$115.96 +0.78 (+0.68%)
Closing price 08/14/2026 03:59 PM Eastern
Extended Trading
$116.24 +0.28 (+0.24%)
As of 08/14/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Oppenheimer

Annual Income Statements for Oppenheimer

This table shows Oppenheimer's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
1.96 -1.16 23 29 53 123 159 32 30 72 148
Consolidated Net Income / (Loss)
2.90 0.49 23 29 53 123 159 32 30 71 148
Net Income / (Loss) Continuing Operations
-2.83 -9.63 22 29 53 123 159 32 30 71 148
Total Pre-Tax Income
-2.43 -22 20 45 75 169 225 46 47 106 211
Total Revenue
898 858 920 912 988 1,183 1,384 1,111 1,249 1,432 1,638
Net Interest Income / (Expense)
0.00 36 77 122 122 18 27 61 105 136 153
Total Interest Income
0.00 36 77 169 168 33 36 61 105 136 153
Investment Securities Interest Income
- - - 52 51 33 36 61 105 136 153
Total Interest Expense
0.00 0.00 0.00 46 46 16 9.86 0.00 0.00 0.00 0.00
Total Non-Interest Income
898 821 843 790 865 1,165 1,358 1,050 1,144 1,297 1,485
Trust Fees by Commissions
418 377 337 330 320 395 402 370 349 410 464
Service Charges on Deposit Accounts
- - - - - 35 16 105 173 139 115
Other Service Charges
33 26 36 16 35 30 29 1.11 24 34 34
Investment Banking Income
383 350 399 430 480 678 887 553 533 660 822
Other Non-Interest Income
64 68 72 14 30 28 24 21 65 55 50
Total Non-Interest Expense
900 880 901 867 913 1,014 1,160 1,065 1,202 1,327 1,427
Salaries and Employee Benefits
611 585 602 607 658 771 887 741 782 937 1,017
Net Occupancy & Equipment Expense
129 131 133 136 144 144 141 145 157 163 169
Other Operating Expenses
160 164 166 124 111 99 132 179 262 227 241
Income Tax Expense
0.41 -12 -2.13 16 22 46 66 13 16 35 63
Net Income / (Loss) Attributable to Noncontrolling Interest
0.94 1.65 - - - 0.00 0.00 -0.24 0.09 -0.31 -0.44
Basic Earnings per Share
$0.14 ($0.09) $2.00 $2.18 $4.10 $9.73 $12.57 $2.77 $2.81 $6.91 $14.13
Weighted Average Basic Shares Outstanding
13.64M 13.37M 13.25M 13.25M 12.90M 12.64M 12.64M 11.67M 10.74M 10.35M 10.50M
Diluted Earnings per Share
$0.14 ($0.09) $2.00 $2.05 $3.82 $9.30 $11.70 $2.57 $2.59 $6.37 $13.04
Weighted Average Diluted Shares Outstanding
13.64M 13.37M 13.67M 14.06M 13.85M 13.22M 13.58M 12.61M 11.65M 11.23M 11.38M
Weighted Average Basic & Diluted Shares Outstanding
14M 12.90M 13.24M 13.30M 13.09M 0.00 0.00 0.00 0.00 0.00 0.00
Cash Dividends to Common per Share
$440.00 $440.00 $1.32 $0.88 $0.46 $1.48 $1.54 $0.60 $0.60 $0.66 $0.72

Quarterly Income Statements for Oppenheimer

This table shows Oppenheimer's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders
11 26 10 25 11 31 22 22 74 -21 27
Consolidated Net Income / (Loss)
12 26 10 25 11 31 22 22 74 -21 27
Net Income / (Loss) Continuing Operations
12 26 10 25 11 31 22 22 74 -21 27
Total Pre-Tax Income
18 37 16 35 17 41 32 32 106 -27 39
Total Revenue
339 353 331 373 418 368 373 424 473 445 455
Net Interest Income / (Expense)
56 27 35 38 78 36 38 39 40 38 39
Total Interest Income
26 27 35 38 36 36 38 39 40 38 39
Investment Securities Interest Income
26 27 35 38 36 36 38 39 40 38 39
Total Interest Expense
-31 0.00 0.00 0.00 -43 0.00 0.00 0.00 - 0.00 0.00
Total Non-Interest Income
282 326 296 335 339 331 335 386 433 408 416
Trust Fees by Commissions
90 96 97 103 114 111 110 121 123 128 128
Service Charges on Deposit Accounts
38 37 35 35 32 30 29 28 28 26 25
Other Service Charges
7.65 10 7.49 9.18 7.02 5.10 13 9.75 6.18 2.88 17
Investment Banking Income
128 165 146 174 174 176 169 212 264 239 230
Other Non-Interest Income
19 18 10 14 12 8.98 15 15 12 11 16
Total Non-Interest Expense
321 316 315 338 401 326 341 393 367 472 415
Salaries and Employee Benefits
193 222 221 238 256 227 239 290 260 296 307
Net Occupancy & Equipment Expense
40 40 40 41 42 42 42 42 44 42 43
Other Operating Expenses
88 54 54 59 103 57 60 61 63 134 65
Income Tax Expense
6.24 12 5.60 11 6.34 11 11 9.92 32 -6.43 12
Net Income / (Loss) Attributable to Noncontrolling Interest
0.50 -0.31 0.00 0.00 - 0.00 0.00 0.00 -0.44 0.01 0.00
Basic Earnings per Share
$1.02 $2.50 $0.99 $2.38 $1.04 $2.93 $2.06 $2.06 $7.08 ($1.93) $2.55
Weighted Average Basic Shares Outstanding
10.74M 10.41M 10.33M 10.33M 10.35M 10.47M 10.52M 10.52M 10.50M 10.64M 10.71M
Diluted Earnings per Share
$1.01 $2.37 $0.92 $2.16 $0.92 $2.72 $1.91 $1.90 $6.51 ($1.93) $2.38
Weighted Average Diluted Shares Outstanding
11.65M 11.00M 11.11M 11.28M 11.23M 11.28M 11.35M 11.45M 11.38M 10.64M 11.48M
Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Annual Cash Flow Statements for Oppenheimer

This table details how cash moves in and out of Oppenheimer's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
-0.44 1.55 -17 43 -11 -44 306 -204 -109 4.32 5.26
Net Cash From Operating Activities
-19 -67 -16 169 79 -54 228 64 -19 -108 189
Net Cash From Continuing Operating Activities
-19 -67 -16 169 79 -54 228 64 -19 -108 189
Net Income / (Loss) Continuing Operations
2.90 0.49 23 29 53 123 159 32 30 71 148
Consolidated Net Income / (Loss)
2.90 0.49 23 29 53 123 159 32 30 71 148
Provision For Loan Losses
0.12 -1.75 -0.03 0.12 -0.44 -0.04 2.90 -2.96 -0.01 -0.14 -0.04
Depreciation Expense
7.20 6.80 5.70 6.87 7.64 8.14 7.99 7.61 9.92 11 11
Amortization Expense
14 15 12 13 13 37 40 41 43 45 44
Non-Cash Adjustments to Reconcile Net Income
7.12 -14 11 -75 47 38 30 21 23 49 37
Changes in Operating Assets and Liabilities, net
-51 -73 -68 194 -41 -260 -12 -34 -126 -284 -50
Net Cash From Investing Activities
-5.89 40 -3.87 -8.19 -8.30 -3.94 -6.27 -14 -16 -3.84 -1.39
Net Cash From Continuing Investing Activities
-5.89 40 -3.87 -8.19 -8.30 -3.94 -6.27 -14 -16 -3.84 -1.39
Purchase of Property, Leasehold Improvements and Equipment
-5.89 -5.73 -5.61 -8.67 -10 -4.53 -8.27 -16 -17 -5.15 -5.19
Purchase of Investment Securities
- 0.00 0.00 - - - 0.00 0.00 -2.93 -2.35 0.00
Sale and/or Maturity of Investments
0.00 0.00 1.74 0.88 1.72 0.59 2.00 2.17 4.42 3.66 3.81
Net Cash From Financing Activities
25 29 3.24 -118 -82 14 85 -254 -75 116 -182
Net Cash From Continuing Financing Activities
25 29 3.24 -118 -82 14 85 -254 -75 116 -182
Issuance of Common Equity
0.00 0.00 0.03 0.07 0.08 0.06 127 0.13 0.08 0.06 0.00
Repayment of Debt
0.00 0.00 -151 0.00 -50 -154 -0.02 -11 -1.00 -113 0.00
Repurchase of Common Equity
-8.25 -3.94 -7.46 -5.89 -8.40 -15 -7.74 -61 -35 -9.60 -2.98
Payment of Dividends
-6.01 -12 -8.28 -6.21 -5.94 -19 -19 -7.04 -6.45 -6.85 -7.58
Other Financing Activities, Net
39 44 -30 -106 -18 76 -15 -175 -32 246 -172
Cash Interest Paid
17 20 24 54 41 19 10 23 68 89 87
Cash Income Taxes Paid
6.09 5.01 2.38 12 17 11 62 38 21 21 46

Quarterly Cash Flow Statements for Oppenheimer

This table details how cash moves in and out of Oppenheimer's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Change in Cash & Equivalents
-28 -1.17 5.55 -0.97 0.91 3.55 0.92 0.67 0.12 -3.80 3.85
Net Cash From Operating Activities
65 -79 -115 11 75 -92 40 63 177 -190 -55
Net Cash From Continuing Operating Activities
65 -79 -115 11 75 -92 40 63 177 -190 -55
Net Income / (Loss) Continuing Operations
12 26 10 25 11 31 22 22 74 -21 27
Consolidated Net Income / (Loss)
12 26 10 25 11 31 22 22 74 -21 27
Provision For Loan Losses
-0.02 0.00 -0.13 -0.01 -0.01 -0.01 0.00 -0.02 -0.02 0.02 0.01
Depreciation Expense
3.34 2.64 2.74 2.74 2.72 2.79 2.74 2.71 2.74 2.48 2.59
Amortization Expense
11 11 11 12 11 11 11 11 10 11 11
Non-Cash Adjustments to Reconcile Net Income
9.51 -1.51 13 15 17 3.32 8.98 15 7.22 21 26
Changes in Operating Assets and Liabilities, net
30 -117 -152 -42 34 -140 -4.52 12 83 -204 -121
Net Cash From Investing Activities
-5.25 -0.26 -1.16 1.87 -4.29 -0.36 -0.90 0.64 -0.77 0.55 -0.98
Net Cash From Continuing Investing Activities
-5.25 -0.26 -1.16 1.87 -4.29 -0.36 -0.90 0.64 -0.77 0.55 -0.98
Purchase of Property, Leasehold Improvements and Equipment
-4.59 -0.26 -1.41 -0.22 -3.26 -1.68 -1.13 -1.21 -1.18 0.00 -2.03
Sale and/or Maturity of Investments
2.26 0.00 0.25 2.09 1.32 1.32 0.23 1.85 0.41 0.55 1.05
Net Cash From Financing Activities
-88 78 122 -14 -70 96 -38 -63 -176 186 60
Net Cash From Continuing Financing Activities
-88 78 122 -14 -70 96 -38 -63 -176 186 60
Payment of Dividends
-1.55 -1.58 -1.55 -1.86 -1.86 -1.90 -1.89 -1.89 -1.89 -12 -2.14
Other Financing Activities, Net
-83 88 124 -12 45 98 -36 -62 -172 198 62
Cash Interest Paid
17 21 20 25 22 21 1.34 45 20 19 0.99
Cash Income Taxes Paid
-0.09 0.77 12 1.36 7.37 0.29 24 12 9.97 1.66 32

Annual Balance Sheets for Oppenheimer

This table presents Oppenheimer's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
2,698 2,237 2,439 2,240 2,465 2,714 3,043 2,714 2,875 3,383 3,722
Cash and Due from Banks
63 65 48 91 80 35 214 112 29 33 38
Trading Account Securities
991 769 969 906 848 694 702 576 880 1,207 1,358
Loans and Leases, Net of Allowance
0.00 0.00 0.00 0.00 0.00 0.00 0.00 57 63 68 58
Loans and Leases
- - - - - - - 57 63 68 58
Customer and Other Receivables
873 877 889 765 797 1,157 1,275 1,203 1,060 1,269 1,415
Premises and Equipment, Net
28 27 27 29 31 28 28 37 44 38 32
Goodwill
138 138 138 138 138 138 138 138 142 144 144
Intangible Assets
32 32 32 32 32 32 32 32 34 36 35
Other Assets
573 328 335 280 539 630 526 533 623 588 642
Total Liabilities & Shareholders' Equity
2,698 2,237 2,439 2,240 2,465 2,714 3,043 2,714 2,875 3,383 3,722
Total Liabilities
2,173 1,724 1,915 1,695 1,872 2,028 2,090 1,894 2,086 2,532 2,725
Short-Term Debt
1,411 1,049 1,184 1,110 1,143 1,105 1,156 1,167 1,372 1,543 1,789
Other Short-Term Payables
258 242 266 255 - 298 342 239 256 331 374
Long-Term Debt
249 295 317 214 150 206 194 113 113 252 77
Other Long-Term Liabilities
255 137 148 116 580 419 398 374 345 406 485
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
525 513 524 545 593 686 825 795 789 850 997
Total Preferred & Common Equity
518 511 524 545 593 686 823 794 789 850 984
Total Common Equity
518 511 524 545 593 686 823 794 789 850 984
Common Stock
102 101 95 95 94 81 78 29 32 30 33
Retained Earnings
417 410 427 450 497 601 741 764 756 820 947
Accumulated Other Comprehensive Income / (Loss)
-0.90 -0.68 1.58 0.17 1.76 3.45 4.23 1.42 0.91 0.69 3.70
Noncontrolling Interest
7.02 2.63 0.36 - - 0.00 2.07 0.72 0.07 0.00 13

Quarterly Balance Sheets for Oppenheimer

This table presents Oppenheimer's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026
Total Assets
2,920 3,092 2,975 3,252 3,263 3,367 3,572 3,687 3,818 3,815 4,231
Cash and Due from Banks
30 29 31 28 33 32 37 38 38 35 38
Trading Account Securities
831 1,000 943 1,142 1,156 1,157 1,314 1,400 1,416 1,380 1,691
Loans and Leases, Net of Allowance
0.00 61 61 0.00 63 66 68 64 67 55 53
Loans and Leases
- 61 61 - 63 66 68 64 67 55 53
Customer and Other Receivables
1,118 1,066 1,087 1,180 1,162 1,296 1,350 1,342 1,375 1,484 1,551
Premises and Equipment, Net
38 43 43 41 40 38 37 35 34 30 29
Goodwill
138 138 138 142 142 142 144 144 144 144 144
Intangible Assets
32 32 32 170 34 34 36 35 35 35 35
Other Assets
706 697 615 548 632 602 588 629 709 653 690
Total Liabilities & Shareholders' Equity
2,920 3,092 2,975 3,252 3,263 3,367 3,572 3,687 3,818 3,815 4,231
Total Liabilities
2,094 2,278 2,170 2,450 2,450 2,529 2,700 2,790 2,898 2,850 3,234
Short-Term Debt
1,375 1,468 1,394 1,231 1,427 1,453 1,579 1,744 1,760 1,720 2,030
Other Short-Term Payables
156 189 224 - 210 262 181 233 320 244 347
Long-Term Debt
132 207 169 207 332 320 360 324 262 288 350
Other Long-Term Liabilities
431 414 383 1,012 483 495 580 490 556 598 507
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
801 788 779 802 812 838 872 897 920 966 997
Total Preferred & Common Equity
800 788 779 802 812 838 872 897 920 952 983
Total Common Equity
800 788 779 802 812 838 872 897 920 952 983
Common Stock
22 26 29 20 23 27 23 27 30 24 28
Retained Earnings
777 762 751 781 789 811 849 868 888 925 950
Accumulated Other Comprehensive Income / (Loss)
0.92 0.26 -0.32 0.53 -0.05 0.22 0.20 2.35 2.80 3.91 5.19
Noncontrolling Interest
0.43 0.11 0.01 0.00 0.00 0.00 - - - 13 13

Annual Metrics And Ratios for Oppenheimer

This table displays calculated financial ratios and metrics derived from Oppenheimer's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics
- - - - - - - - - - -
Profitability Metrics
- - - - - - - - - - -
Valuation Ratios
- - - - - - - - - - -
Leverage & Solvency
- - - - - - - - - - -
Liquidity Ratios
- - - - - - - - - - -
Cash Flow Metrics
- - - - - - - - - - -
Efficiency Ratios
- - - - - - - - - - -
Capital & Investment Metrics
- - - - - - - - - - -
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.14 $0.00 $0.00 $2.18 $4.10 $9.73 $12.57 $2.77 $2.81 $6.91 $14.13
Adjusted Weighted Average Basic Shares Outstanding
13.64M 13.37M 13.25M 13.25M 12.90M 12.64M 12.64M 11.67M 10.74M 10.35M 10.50M
Adjusted Diluted Earnings per Share
$0.14 ($0.09) $1.67 $2.05 $3.82 $9.30 $11.70 $2.57 $2.59 $6.37 $13.04
Adjusted Weighted Average Diluted Shares Outstanding
14.29M 13.37M 13.67M 14.06M 13.85M 13.22M 13.58M 12.61M 11.65M 11.23M 11.38M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $4.10 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
13.41M 13.44M 13.24M 13.05M 13.09M 12.68M 12.42B 0.00 0.00 0.00 0.00
Debt Service Ratios
- - - - - - - - - - -
Payout Ratios
- - - - - - - - - - -

Quarterly Metrics And Ratios for Oppenheimer

This table displays calculated financial ratios and metrics derived from Oppenheimer's official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
DEI Shares Outstanding
- - - - - - - - - 10,707,255.00 10,708,005.00
DEI Adjusted Shares Outstanding
- - - - - - - - - 10,707,255.00 10,708,005.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - -1.92 2.55
Growth Metrics
- - - - - - - - - - -
Revenue Growth
3.72% 7.80% 6.89% 19.41% 23.32% 4.16% 12.88% 13.68% - 21.01% 21.89%
EBITDA Growth
-23.81% 62.66% 1,964.09% 41.72% -4.32% 7.91% 55.54% -8.42% - -123.84% 14.23%
EBIT Growth
-41.09% 96.62% 235.61% 63.85% -4.30% 10.47% 103.03% -10.56% - -165.26% 22.46%
NOPAT Growth
-48.20% 77.99% 225.36% 77.86% -7.48% 19.08% 111.12% -11.41% - -161.66% 26.19%
Net Income Growth
-48.20% 77.99% 207.30% 77.86% -7.48% 19.08% 111.12% -11.41% - -167.10% 26.19%
EPS Growth
-44.81% 94.26% 208.24% 78.51% -8.91% 14.77% 107.61% -12.04% - -170.96% 24.61%
Operating Cash Flow Growth
-55.68% 8.22% -78.19% -82.83% 14.21% -16.06% 134.76% 454.69% - -107.09% -237.33%
Free Cash Flow Firm Growth
-171.66% -12.50% 76.93% -84.30% -125.35% -554.33% -423.97% -43.24% - 66.48% -3.43%
Invested Capital Growth
8.19% -3.99% 3.27% 10.20% 16.38% 25.49% 15.33% 12.74% - 5.77% 13.91%
Revenue Q/Q Growth
8.39% 14.67% -7.21% 20.98% 11.94% -11.99% 1.46% 13.74% - -5.83% 2.20%
EBITDA Q/Q Growth
-8.31% 58.87% -41.99% 67.72% -38.09% 79.18% -16.39% -1.25% - -111.07% 500.62%
EBIT Q/Q Growth
-17.39% 110.03% -57.64% 122.94% -51.75% 142.43% -22.15% -1.79% - -125.48% 246.09%
NOPAT Q/Q Growth
-15.84% 121.99% -60.12% 138.73% -56.22% 185.72% -29.30% 0.18% - -125.57% 244.71%
Net Income Q/Q Growth
-15.84% 121.99% -60.12% 138.73% -56.22% 185.72% -29.30% 0.18% - -127.83% 232.97%
EPS Q/Q Growth
-16.53% 134.65% -61.18% 134.78% -57.41% 195.65% -29.78% -0.52% - -129.65% 223.32%
Operating Cash Flow Q/Q Growth
-1.76% -220.84% -45.82% 109.92% 553.42% -222.79% 143.68% 58.28% - -207.33% 71.04%
Free Cash Flow Firm Q/Q Growth
-36.30% 174.08% -159.75% -205.47% -66.65% -49.36% 31.09% 16.49% - -26.75% -112.60%
Invested Capital Q/Q Growth
-4.01% -1.47% 14.75% 1.53% 1.38% 6.24% 5.46% -0.74% - 3.86% 13.58%
Profitability Metrics
- - - - - - - - - - -
EBITDA Margin
9.50% 15.37% 9.61% 13.32% 7.37% 15.00% 12.36% 10.73% - -2.96% 11.59%
EBIT Margin
5.26% 11.26% 5.14% 9.47% 4.08% 11.25% 8.63% 7.45% - -6.07% 8.67%
Profit (Net Income) Margin
3.42% 7.74% 3.33% 6.56% 2.57% 8.33% 5.81% 5.12% - -4.62% 6.01%
Tax Burden Percent
65.03% 68.73% 64.71% 69.29% 62.86% 74.09% 67.29% 68.63% - 76.18% 69.34%
Interest Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% - 100.00% 100.00%
Effective Tax Rate
34.97% 31.27% 35.29% 30.71% 37.14% 25.91% 32.71% 31.37% - 0.00% 30.66%
Return on Invested Capital (ROIC)
1.95% 4.08% 1.61% 3.39% 1.50% 4.78% 3.13% 2.84% - -2.52% 3.41%
ROIC Less NNEP Spread (ROIC-NNEP)
1.95% 4.08% 1.61% 3.39% 1.50% 4.78% 3.13% 2.84% - -2.60% 3.41%
Return on Net Nonoperating Assets (RNNOA)
3.36% 7.38% 3.40% 6.88% 2.99% 9.64% 7.00% 6.13% - -5.59% 8.01%
Return on Equity (ROE)
5.31% 11.45% 5.01% 10.27% 4.49% 14.41% 10.13% 8.97% - -8.11% 11.41%
Cash Return on Invested Capital (CROIC)
-6.48% 5.89% -0.79% -6.81% -12.25% -19.59% -11.07% -8.93% - -2.26% -9.78%
Operating Return on Assets (OROA)
2.35% 4.39% 1.98% 3.84% 1.87% 4.77% 3.70% 3.20% - -2.82% 3.94%
Return on Assets (ROA)
1.53% 3.02% 1.28% 2.66% 1.18% 3.53% 2.49% 2.19% - -2.15% 2.73%
Return on Common Equity (ROCE)
5.22% 11.27% 4.93% 10.10% 4.49% 14.41% 10.13% 8.97% - -8.05% 11.33%
Return on Equity Simple (ROE_SIMPLE)
0.00% 5.18% 7.56% 8.61% 0.00% 8.73% 9.76% 9.21% - 10.16% 10.41%
Net Operating Profit after Tax (NOPAT)
12 26 10 25 11 31 22 22 - -19 27
NOPAT Margin
3.42% 7.74% 3.33% 6.56% 2.57% 8.33% 5.81% 5.12% - -4.25% 6.01%
Net Nonoperating Expense Percent (NNEP)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.08% 0.00%
SG&A Expenses to Revenue
68.78% 78.82% 84.55% 74.67% 71.35% 73.21% 75.26% 78.25% - 76.02% 77.05%
Operating Expenses to Revenue
94.74% 88.74% 94.86% 90.53% 95.92% 88.75% 91.37% 92.55% - 106.07% 91.33%
Earnings before Interest and Taxes (EBIT)
18 37 16 35 17 41 32 32 - -27 39
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
32 51 30 50 31 55 46 46 - -13 53
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.53 0.52 0.61 0.63 0.78 0.72 0.77 0.84 - 1.00 1.15
Price to Tangible Book Value (P/TBV)
0.69 0.85 0.78 0.80 0.98 0.91 0.96 1.05 - 1.23 1.40
Price to Revenue (P/Rev)
0.34 0.34 0.40 0.41 0.46 0.43 0.46 0.50 - 0.56 0.63
Price to Earnings (P/E)
13.97 9.96 8.05 7.35 9.23 8.24 7.91 9.17 - 9.83 10.99
Dividend Yield
1.48% 1.51% 1.26% 1.23% 1.03% 1.16% 1.09% 0.97% - 1.93% 0.70%
Earnings Yield
7.16% 10.04% 12.43% 13.61% 10.84% 12.13% 12.65% 10.90% - 10.18% 9.10%
Enterprise Value to Invested Capital (EV/IC)
0.83 0.81 0.86 0.87 0.92 0.90 0.92 0.94 - 0.99 1.03
Enterprise Value to Revenue (EV/Rev)
1.50 1.52 1.81 1.77 1.69 1.75 1.83 1.79 - 1.71 1.94
Enterprise Value to EBITDA (EV/EBITDA)
18.74 15.23 14.98 13.94 15.02 15.30 14.97 15.54 - 14.90 17.09
Enterprise Value to EBIT (EV/EBIT)
40.13 28.01 23.92 21.30 22.91 23.06 21.60 22.58 - 20.59 23.23
Enterprise Value to NOPAT (EV/NOPAT)
62.00 43.93 36.14 31.46 34.00 33.22 31.09 32.58 - 30.40 34.03
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00 78.96 31.94 - 32.49 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 13.55 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
1.88 1.79 2.17 2.12 2.11 2.22 2.31 2.20 - 2.08 2.39
Long-Term Debt to Equity
0.14 0.26 0.41 0.38 0.30 0.41 0.36 0.29 - 0.30 0.35
Financial Leverage
1.72 1.81 2.11 2.03 2.00 2.02 2.24 2.16 - 2.15 2.35
Leverage Ratio
3.47 3.79 3.91 3.86 3.82 4.08 4.07 4.09 - 4.02 4.18
Compound Leverage Factor
3.47 3.79 3.91 3.86 3.82 4.08 4.07 4.09 - 4.02 4.18
Debt to Total Capital
65.28% 64.22% 68.41% 67.90% 67.86% 68.97% 69.75% 68.72% - 67.52% 70.49%
Short-Term Debt to Total Capital
60.33% 54.97% 55.51% 55.65% 58.33% 56.18% 58.82% 59.81% - 57.84% 60.12%
Long-Term Debt to Total Capital
4.96% 9.24% 12.90% 12.24% 9.53% 12.79% 10.92% 8.91% - 9.68% 10.36%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.44% 0.39%
Common Equity to Total Capital
34.71% 35.78% 31.59% 32.10% 32.14% 31.03% 30.25% 31.28% - 32.03% 29.12%
Debt to EBITDA
14.82 12.00 11.87 10.89 11.13 11.72 11.37 11.38 - 10.17 11.67
Net Debt to EBITDA
14.53 11.77 11.65 10.69 10.92 11.50 11.16 11.17 - 10.00 11.48
Long-Term Debt to EBITDA
1.12 1.73 2.24 1.96 1.56 2.17 1.78 1.48 - 1.46 1.72
Debt to NOPAT
49.03 34.62 28.65 24.57 25.20 25.46 23.61 23.86 - 20.75 23.24
Net Debt to NOPAT
48.08 33.95 28.10 24.13 24.74 24.97 23.18 23.40 - 20.40 22.87
Long-Term Debt to NOPAT
3.72 4.98 5.40 4.43 3.54 4.72 3.70 3.09 - 2.98 3.42
Noncontrolling Interest Sharing Ratio
1.63% 1.60% 1.60% 1.58% 0.00% 0.00% 0.00% 0.00% - 0.72% 0.70%
Liquidity Ratios
- - - - - - - - - - -
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-161 119 -71 -217 -362 -540 -372 -311 - -181 -385
Operating Cash Flow to CapEx
1,426.43% -30,638.76% -8,180.70% 5,197.27% 2,291.08% -5,457.47% 3,555.37% 5,258.96% - 0.00% -2,710.59%
Free Cash Flow to Firm to Interest Expense
0.00 5.79 -3.23 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 -3.85 -5.24 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 -3.86 -5.31 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.45 0.39 0.39 0.41 0.46 0.42 0.43 0.43 - 0.46 0.45
Fixed Asset Turnover
30.98 30.15 29.59 32.01 34.91 36.84 39.39 43.04 - 51.20 55.44
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
2,273 2,240 2,571 2,610 2,646 2,811 2,964 2,943 - 2,973 3,377
Invested Capital Turnover
0.57 0.53 0.48 0.52 0.58 0.57 0.54 0.56 - 0.59 0.57
Increase / (Decrease) in Invested Capital
172 -93 81 242 372 571 394 333 - 162 412
Enterprise Value (EV)
1,877 1,825 2,218 2,268 2,423 2,530 2,722 2,762 - 2,941 3,485
Market Capitalization
422 414 493 529 660 628 692 778 - 955 1,130
Book Value per Share
$76.06 $76.65 $78.62 $81.09 $82.31 $82.87 $85.21 $87.47 - $88.95 $91.84
Tangible Book Value per Share
$59.05 $46.76 $61.55 $64.03 $64.96 $65.85 $68.20 $70.48 - $72.28 $75.19
Total Capital
2,273 2,240 2,571 2,610 2,646 2,811 2,964 2,943 - 2,973 3,377
Total Debt
1,484 1,439 1,758 1,772 1,796 1,939 2,068 2,022 - 2,008 2,380
Total Long-Term Debt
113 207 332 320 252 360 324 262 - 288 350
Net Debt
1,455 1,411 1,725 1,740 1,762 1,902 2,030 1,984 - 1,973 2,342
Capital Expenditures (CapEx)
4.59 0.26 1.41 0.22 3.26 1.68 1.13 1.21 - 0.00 2.03
Net Nonoperating Expense (NNE)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 1.67 0.00
Net Nonoperating Obligations (NNO)
1,484 1,439 1,758 1,772 1,796 1,939 2,068 2,022 - 2,008 2,380
Total Depreciation and Amortization (D&A)
14 14 14 14 14 14 14 14 - 14 13
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$1.02 $2.50 $0.99 $2.38 $1.04 $2.93 $2.06 $2.06 $7.08 ($1.93) $2.55
Adjusted Weighted Average Basic Shares Outstanding
10.74M 10.41M 10.33M 10.33M 10.35M 10.47M 10.52M 10.52M 10.50M 10.64M 10.71M
Adjusted Diluted Earnings per Share
$1.01 $2.37 $0.92 $2.16 $0.92 $2.72 $1.91 $1.90 $6.51 ($1.93) $2.38
Adjusted Weighted Average Diluted Shares Outstanding
11.65M 11.00M 11.11M 11.28M 11.23M 11.28M 11.35M 11.45M 11.38M 10.64M 11.48M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Normalized Net Operating Profit after Tax (NOPAT)
12 26 10 25 11 31 22 22 - -19 27
Normalized NOPAT Margin
3.42% 7.74% 3.33% 6.56% 2.57% 8.33% 5.81% 5.12% - -4.25% 6.01%
Pre Tax Income Margin
5.26% 11.26% 5.14% 9.47% 4.08% 11.25% 8.63% 7.45% - -6.07% 8.67%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 1.82 0.72 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
NOPAT to Interest Expense
0.00 1.25 0.47 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 1.81 0.66 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 1.24 0.40 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
21.31% 15.29% 10.18% 9.06% 9.61% 9.41% 8.57% 8.90% - 18.70% 17.91%
Augmented Payout Ratio
137.34% 111.13% 70.70% 27.76% 23.09% 11.13% 9.68% 9.69% - 21.69% 20.16%

Financials Breakdown Chart

Key Financial Trends

Oppenheimer Holdings (NYSE: OPY) showed a sharp reset in early 2026 after a profitable 2025, with the latest quarter swinging to a loss and operating cash flow turning deeply negative. Revenue held up reasonably well, but expense pressure and a weak mix of business lines led to a meaningful deterioration in earnings and cash generation.

  • Q1 2026 retained a sizable revenue base at $445.1 million, only modestly below Q4 2025’s $472.6 million.
  • Non-interest income remained the main driver of the business, contributing $407.6 million in Q1 2026.
  • The company continues to carry a strong equity base, with $952.4 million in total common equity at March 31, 2026.
  • Retained earnings were solid at $924.9 million, indicating the company has built up a meaningful earnings cushion over time.
  • Total assets were fairly stable sequentially at $3.82 billion, up slightly from $3.82 billion in Q3 2025.
  • Cash and due from banks increased to $34.6 million from $38.3 million in Q3 2025, but cash remained a relatively small part of the balance sheet.
  • Investment banking income remained volatile but still meaningful, falling to $239.4 million from $264.4 million in Q4 2025.
  • Q1 2026 posted a net loss of $20.6 million, versus $73.9 million of net income in Q4 2025.
  • Earnings per share turned negative at -$1.93, down from $7.08 in the prior quarter.
  • Operating cash flow was a major weak point, with -$190.0 million from operations in Q1 2026 compared with $177.0 million in Q4 2025.

What changed in the latest quarter? The biggest issue was that expenses outpaced revenue. Total non-interest expense rose to $472.1 million, above total revenue of $445.1 million, producing a pre-tax loss of $27.0 million. In contrast, Q4 2025 delivered $105.97 million of pre-tax income.

Looking at the recent trend, OPY’s results have been choppy but still profitable overall until this quarter. In 2025, the company produced strong quarters in Q3 and Q4, including $21.7 million of net income in Q3 2025 and $73.9 million in Q4 2025. Q1 2026 reversed that momentum, suggesting the earnings base is sensitive to market activity and operating leverage.

Balance sheet trends are mixed. Debt remains significant, with $1.72 billion of short-term debt and $287.9 million of long-term debt at Q1 2026. That said, shareholders’ equity is still substantial, and book value improved meaningfully over the past year, rising from $872.3 million in Q1 2025 to $952.4 million in Q1 2026.

Cash flow deserves close attention. The company generated negative operating cash flow in Q1 2026 even after adding back non-cash items, which suggests working capital and/or business mix issues weighed heavily. Financing inflows helped offset some of that pressure, but they do not solve the underlying operating weakness.

Bottom line: Oppenheimer still has a solid capital base and a large recurring fee-driven revenue stream, but Q1 2026 was a clear setback. Investors should watch whether the company can restore operating profitability and positive cash flow in upcoming quarters, especially since a business like this can move quickly with market conditions and deal activity.

08/16/26 11:43 AM ETAI Generated. May Contain Errors.

Oppenheimer Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Oppenheimer's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Oppenheimer's net income appears to be on an upward trend, with a most recent value of $147.96 million in 2025, rising from $2.90 million in 2015. The previous period was $71.25 million in 2024. See where experts think Oppenheimer is headed by visiting Oppenheimer's forecast page.

Over the last 10 years, Oppenheimer's total revenue changed from $897.80 million in 2015 to $1.64 billion in 2025, a change of 82.5%.

Oppenheimer's total liabilities were at $2.73 billion at the end of 2025, a 7.6% increase from 2024, and a 25.4% increase since 2015.

In the past 10 years, Oppenheimer's cash and equivalents has ranged from $28.84 million in 2023 to $213.76 million in 2021, and is currently $38.41 million as of their latest financial filing in 2025.



Financial statements for NYSE:OPY last updated on 7/31/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners